Latest Aggregates News

Elevate Uranium has intersected a significant 13-meter thick uranium mineralisation zone in granite at its Marenica Project, revealing a new style of deposit beyond traditional palaeochannels. This discovery could reshape exploration strategies and resource potential in Namibia.

Freehill Mining has successfully produced a high-grade 65.75% iron concentrate from a 400kg bulk sample at its Yerbas Buenas Mine in Chile, setting the stage for a potential restart of magnetite mining operations.

Freehill Mining has produced a high-grade magnetite concentrate of approximately 66% iron from its Yerbas Buenas mine bulk sample, setting the stage for renewed mining operations in Chile.

Web Travel Group Limited reported a robust 22% increase in Total Transaction Value for FY25, despite a 14% dip in EBITDA due to margin pressures and higher costs. The company is strategically investing in supply and technology to target $10 billion TTV by FY30.

Adavale Resources plans a significant 20:1 share consolidation to streamline its capital structure and attract institutional investors, coinciding with promising exploration progress at its Parkes Gold and Copper Project.

Dateline Resources Limited has updated its scoping study for the Colosseum Gold Project in California, incorporating a revised gold price of US$2,900/oz that significantly enhances the project's economic outlook. The study confirms robust project fundamentals and sets the stage for a Definitive Feasibility Study.

Monadelphous Group Limited has landed a suite of new contracts worth approximately $180 million across Western Australia's resources, energy, and infrastructure sectors, reinforcing its strong foothold in the region.

Fletcher Building is dissolving its Australian Division, folding operations into two new trans-Tasman units, while targeting $15 million in annual cost savings as market challenges persist.

Aristocrat Leisure Limited reported a robust HY25 with revenue rising 9% to AUD 3 billion and a 6% increase in NPATA, underpinned by strategic acquisitions and operational resilience. The company signals confidence in sustained growth through innovation and market expansion.

Credit Corp Group maintains its FY25 NPAT guidance amid operational gains in US debt buying and cautious optimism in Australian/New Zealand lending markets.

Alterity Therapeutics is set to present compelling Phase 2 clinical trial results for ATH434 at the 2025 International Multiple System Atrophy Congress, highlighting slowed disease progression and biomarker engagement in MSA patients.

Eden Innovations has secured its inaugural order from Holcim Mexico for EdenCretePz7, marking a strategic expansion into a major new market and extending its footprint within the global Holcim Group.